Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future
{{output}}
Amyloid β protein (Aβ) is the main component of neuritic plaques in Alzheimer's disease (AD), and its accumulation has been considered as the molecular driver of Alzheimer's pathogenesis and progression. Aβ has been the prime target for the development of A... ...